IRCT2017012232125N1已完成2 期
efficacy of rituximab in treatmeantof plasma exchange refractory TTP
vice chancellor for research of esfahan university of medical sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •exclusion:viral infection, malignancy,autoimmune disease,drug(cyclosporine,ticlopidine,..)
- •inclusion:criteria for ttp diagnosis
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitisEUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106
进行中（未招募）
1 期
to evaluate a triple therapy: plasma exchange, rituximab, intravenous immunoglobulin (IVIg) and corticosteroid administration compared to standard corticosteroid therapy in patients for severe acute exacerbation of idiopathic pulmonarysevere acute exacerbation of idiopathic pulmonary fibrosisEUCTR2018-002632-24-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)40
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10
已完成
2 期
The efficacy of rituximab for recalcitrant Pemphigus Vulgaris in the patients of Razi hospital from 2007 to 2011Pemphigus vulgaris.Pemphigus vulgarisIRCT201111022704N2Vice-chancellor for Research of Tehran University of Medical Sciences40
尚未招募
2 期
Study of efficacy of rituximab drug for topical application in oral mucosa in pemphigus vulgaris patients.CTRI/2018/05/014187Dr SUJAY KHANDPUR